Does a supraventricular tachycardia (SVT) electrocardiogram (ECG) show visible P waves?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

P Wave Characteristics in Supraventricular Tachycardia (SVT)

In supraventricular tachycardia (SVT), P waves are present in approximately 60% of cases but typically have a different morphology from sinus P waves and may be hidden within the QRS complex. 1

P Wave Visibility and Characteristics in Different SVT Types

AVNRT (AV Nodal Reentrant Tachycardia)

  • Most common form of SVT (140-250 bpm) 2
  • P waves are often hidden within the QRS complex 1
  • When visible, P waves may appear as:
    • Pseudo-R wave in lead V1
    • Pseudo-S wave in inferior leads (II, III, aVF) 1
  • These findings are pathognomonic for AVNRT when present

AVRT (AV Reciprocating Tachycardia)

  • P waves are typically visible after the QRS complex
  • RP interval usually exceeds 70 ms 3
  • P wave morphology differs from sinus P waves 1

Atrial Tachycardia

  • P waves are usually visible but with abnormal morphology
  • P waves precede each QRS complex

Diagnostic Approach to SVT

ECG Criteria for Narrow QRS Tachycardia

  • If no P waves are apparent and RR interval is regular, AVNRT is most likely 1
  • If P wave is present in ST segment and separated from QRS by 70 ms, AVRT is most likely 1
  • In tachycardias with RP longer than PR, consider:
    • Atypical AVNRT
    • Permanent form of junctional reciprocating tachycardia (PJRT)
    • Atrial tachycardia 1

Differential Diagnosis

  • Narrow QRS complex (< 120 ms) almost always indicates SVT 1
  • Regular rhythm with rates typically 150-250 bpm 3
  • P waves may be:
    • Hidden within QRS complex (especially in AVNRT)
    • Visible but with abnormal morphology
    • Following QRS complex (in AVRT) 4

Clinical Implications

Diagnostic Challenges

  • P waves may be difficult to identify during tachycardia
  • Consider using:
    • 12-lead ECG (rather than single lead monitoring)
    • Esophageal pill electrodes when P waves are not visible 1
    • Response to adenosine or carotid massage to help reveal P waves 1

Common Pitfalls

  • Misdiagnosing wide-complex tachycardia as SVT when it could be ventricular tachycardia 2
  • Failing to obtain a 12-lead ECG during tachycardia 1
  • Overlooking subtle P waves that may be partially hidden within the QRS complex
  • Misinterpreting artifact as P waves

Management Considerations

  • Vagal maneuvers are first-line for acute termination and may help reveal P waves 2
  • Adenosine administration can terminate most SVTs and may transiently block AV conduction, revealing underlying atrial activity 2
  • Beta-blockers or calcium channel blockers are recommended as first-line pharmacologic therapy 2
  • Electrophysiology study should be considered for recurrent symptomatic episodes 2

In summary, while P waves are present in most SVTs, they may be difficult to visualize on standard ECG due to their timing relative to the QRS complex or their abnormal morphology. Their presence, location, and morphology provide valuable diagnostic information about the specific type of SVT mechanism.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Supraventricular Arrhythmias

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Paroxysmal supraventricular tachycardias.

The Journal of emergency medicine, 1996

Research

Paroxysmal Supraventricular Tachycardia: Pathophysiology, Diagnosis, and Management.

Critical care nursing clinics of North America, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.